Philippe Parone

Chief Scientific Officer at EsoBiotec

Brussels Metropolitan Area

About

Innovative scientist and dedicated program leader with over 20 years of experience in academic and biotech research, the last 9 years focusing on commercial development of cellular therapeutics in cancer, and autoimmune and neurodegenerative disorders. Strategic forward thinker with strong abilities to manage complex programs and motivate multi-disciplinary teams to evaluate and develop cell therapy products. Effective communicator comfortable with relating concepts and ideas to diverse audiences and championing programs internally to board level staff and at international conferences. Open communication style and skilled in forming collaborative relationships with colleagues and external partners including leading KOLs at academic institutions and CROs. Adaptable, creative and thriving when initiating and promoting change. Reputation for accountability, integrity, enthusiasm and positive approach.

Experience

  • EsoBiotec (Full-time · 5 yrs 6 mos)
    • VP, Research and Development
      Jan 2021 - Present · 5 yrs 6 mos

      - Define company's R&D strategy - Lead internal and outsourced R&D activities - Manage R&D personnel - Represent company in external interactions

    • Chief Scientific Officer
      Jan 2021 - Present · 5 yrs 6 mos

  • Director, Industrialization at Celyad
    Apr 2019 - Dec 2020 · 1 yr 9 mos

  • Fate Therapeutics Inc (6 yrs 2 mos)
    • Associate Director, Immunotherapy
      Jan 2016 - Apr 2019 · 3 yrs 4 mos

    • Senior Scientist, Research and development
      Jan 2015 - Dec 2015 · 1 yr

    • Scientist, Research and development
      Mar 2013 - Dec 2014 · 1 yr 10 mos

  • Post-doctoral fellow at Ludwig Institute for Cancer Research
    Aug 2006 - Mar 2013 · 6 yrs 8 mos

    Determine the pathogenic contribution of mitochondrial dysfunction in Amyotrophic Lateral Sclerosis using mouse genetics

  • Post-doctoral fellow at University of Geneva
    Jan 2001 - May 2006 · 5 yrs 5 mos

    Determine the role of mitochondrial fission and fusion in apoptosis and mammalian cellular homeostasis